Catherine Guittet
Corporate Officer/Principal at ADVICENNE
Profile
Catherine Guittet is currently the Head of Clinical Operations Department at Advicenne SA since 2008.
Prior to this, she worked as the Head of Patients Clinical Study Unit at SGS Aster SAS, Head of Clinical Department at Synt:em SA, Head of Project Management at Sanofi Aventis Participations SAS, and as a Principal at Merck Serono SAS.
Dr. Guittet holds a doctorate degree from L'Université d'Angers and an undergraduate degree from Université Paris Diderot-Paris 7.
Catherine Guittet active positions
Companies | Position | Start |
---|---|---|
ADVICENNE | Corporate Officer/Principal | 2007-12-31 |
Former positions of Catherine Guittet
Companies | Position | End |
---|---|---|
SGS Aster SAS
SGS Aster SAS Miscellaneous Commercial ServicesCommercial Services SGS Aster SAS provides clinical pharmacology trials and bioanalytical drug development services. The company is based in Paris, France. The French company was founded in 1992 by John J. Thebault. SGS Aster was acquired by SGS SA on January 05, 2006. | Corporate Officer/Principal | - |
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Corporate Officer/Principal | - |
Merck Serono SAS
Merck Serono SAS Pharmaceuticals: MajorHealth Technology Merck Serono SAS manufactures, develops, and sells pharmaceutical drugs and products. It offers medicines for diseases such as cancer, multiple sclerosis, infertility, endocrine, cardio-metabolic disorders, and psoriasis. The company was founded in 1955 and is headquartered in Lyon, France. | Corporate Officer/Principal | - |
Sanofi Aventis Participations SAS
Sanofi Aventis Participations SAS Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Aventis Participations SAS is a pharmaceutical company based in Paris, France. The French company manufactures pharmaceuticals. The CEO of the company is Mathias Thibault. | Corporate Officer/Principal | - |
Training of Catherine Guittet
L'Université d'Angers | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ADVICENNE | Health Technology |
Private companies | 5 |
---|---|
Sanofi Aventis Participations SAS
Sanofi Aventis Participations SAS Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Aventis Participations SAS is a pharmaceutical company based in Paris, France. The French company manufactures pharmaceuticals. The CEO of the company is Mathias Thibault. | Health Technology |
Synt:em SA
Synt:em SA Pharmaceuticals: MajorHealth Technology Synt:em SA researches and manufactures drugs for the treatment of pain and cancer. The company specializes in the discovery and development of Central Nervous System (CNS) medicines and novel therapeutics for the treatment diseases. It was founded in 1995 by Michel Kaczorek and Caroline Roussel and is headquartered in Nîmes, France. | Health Technology |
Merck Serono SAS
Merck Serono SAS Pharmaceuticals: MajorHealth Technology Merck Serono SAS manufactures, develops, and sells pharmaceutical drugs and products. It offers medicines for diseases such as cancer, multiple sclerosis, infertility, endocrine, cardio-metabolic disorders, and psoriasis. The company was founded in 1955 and is headquartered in Lyon, France. | Health Technology |
Université Paris Diderot-Paris 7 | Consumer Services |
SGS Aster SAS
SGS Aster SAS Miscellaneous Commercial ServicesCommercial Services SGS Aster SAS provides clinical pharmacology trials and bioanalytical drug development services. The company is based in Paris, France. The French company was founded in 1992 by John J. Thebault. SGS Aster was acquired by SGS SA on January 05, 2006. | Commercial Services |
- Stock Market
- Insiders
- Catherine Guittet